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3) Capping: A solution of Ac 2 O (5.3 equiv) and 2,6-lutidine (6.4 equiv) in DMF was added to the resin (3 mL). After 3 min the resin was washed with DMF (5 × 3 mL), CH 2 Cl 2 (5 × 3 mL) and DMF (5 × 3 mL).
Cleavage: An acidic cocktail comprising TFA/iPr 3 SiH/H 2 O (95:2.5:2.5, v/v/v, 3 mL) was added to the resin. After 1 h the resin was washed with TFA (3 × 2 mL).
Work-up:
The combined solutions were concentrated under a stream of nitrogen. The residue was dissolved in H 2 O containing 0.1% TFA, filtered and purified by preparative HPLC and analyzed by LC-MS and ESI mass spectrometry.
Automated PNA Synthesis
PNA synthesis was performed using an automated peptide synthesizer (Intavis MultiPep instrument in 500 µL fritted tubes.). The resin (5 mg, 1 µmol per column) was swollen in DCM (300 µL) for 20 min. Standard couplings were performed by treatment of the resin with a preactivated (5 min) solution of the corresponding protected PNA monomer/amino acid (5 eq.), HATU (4 eq.), DIPEA (5 eq.), and 2,6-lutidine (7.5 eq.) for 20 min in NMP. This process was repeated once (double couplings). Each coupling was followed by a capping step with Ac 2 O (5.3 eq.) and 2,6-lutidine (6.4 eq.) in DMF (150 µL per column).
General Procedures Solution Phase Selenoester Synthesis
Cleavage of the PNA-peptides from the resin was effected by treating with 30 vol.% HFIP in DCM for 2 h before concentrating in vacuo. The resulting residue was dissolved in anhydrous DMF and cooled to 0 °C. Diphenyl diselenide (DPDS) (2.5 eq. in DMF) was added to the solution followed by Bu 3 P (5 eq.). The reaction was allowed to proceed at 0 °C for 3 h, after which time the solvent was removed in vacuo. The crude material was put on ice and the protecting groups removed via treatment with TFA:TIS:H 2 O (95:2.5:2.5 v/v/v). After 1 h at room temperature the cleavage cocktail was removed under a stream of N 2 and the crude residue suspended in diethyl ether and cooled to -20 °C.
The precipitate was pelleted by centrifugation at 4000 rpm for 5 min, the supernatant decanted and the pellet dissolved in 0.1% TFA/H 2 O with addition of 0.1% TFA/MeCN and purified via preparative HPLC.
Solid Phase Selenoester Synthesis
Following elongation of the PNA/peptide, the resin was swollen in anhydrous CH 2 Cl 2 for 5 mins. The vessel was then purged with N 2 , the solvent drained and a solution of Pd(PPh 3 ) 4 (0.25 eq.) in S6 anhydrous CH 2 Cl 2 was added, followed by PhSiH 3 (24 eq.) maintaining an inert atmosphere. The resin was then gently agitated for 1 h. The resin was then drained and washed with CH 2 Cl 2 (5 x 3 mL) and DMF (5 x 3 mL). To effect the selenoesterification reaction, a solution of DPDS (2.5 eq.) and Bu 3 P (5.0 eq.) in anhydrous DMF was added to the resin in an inert atmosphere. The resin was agitated for 3 h and then washed with DMF (5 x 3 mL), CH 2 Cl 2 (5 x 3 mL) and DMF (5 x 3 mL). The crude material was put on ice and the protecting groups removed via treatment with TFA:TIS:H 2 O (95:2.5:2.5 v/v/v). After 1 h at room temperature the cleavage cocktail was removed under a stream of N 2 and the crude residue suspended in diethyl ether and cooled to -20 °C. The precipitate was pelleted by centrifugation at 4000 rpm for 5 min, the supernatant decanted and the pellet dissolved in 0.1% TFA/H 2 O with addition of 0.1% TFA/MeCN and purified via preparative HPLC.
Selenocystine-selenoester Ligation Reaction
PNA-peptide selenoesters and PNA-peptide dimers bearing N-terminal selenocystine were dissolved in DMF as 1 mM stock solutions. Aliquots of the selenoester (1.0 eq.) and diselenide dimer (0.5 eq.) stock solutions were taken and added to PBS buffer to the desired overall concentration. The ligation reaction was gently agitated and allowed to proceed for the specified time before analysis by LCMS.
Synthesis of Model PNA-Peptides

PNA-Peptide Selenoester (1) (H 2 N-[GCCG]-Ala-SePh)
2-chlorotrityl chloride resin (50 mg, 1.6 mmol/g, 80 µmol) was loaded with Fmoc-Ala-OH (75 mg, 3 eq., 240 µmol) as outlined in the general pre-loading procedure, and extended at the N-terminus with PNA monomers via automated Fmoc-strategy solid-phase synthesis to the desired sequence length.
The protected PNA-peptide was cleaved from the resin using 30 vol.% HFIP in DCM and selenoesterified as outlined in the general methods section. The crude residue was purified by preparative reverse-phase HPLC (10 to 50% B over 15 min, 0.1% TFA) and lyophilized to afford the desired selenoester 1 as a white solid following lyophilisation. NovaPEG Rink amide resin (20 mg, 0.5 mmol/g, 10 µmol) was swollen in CH 2 Cl 2 for 30 minutes.
The desired PNA-peptide sequence was then elongated via automated Fmoc-SPPS as outlined in the general procedures. Coupling of (Boc-Sec-OH) 2 was then performed manually by treatment of the resin with a pre-activated solution of (Boc-Sec-OH) 2 (5.3 mg, 1.0 eq., 10 µmol), HOAt (33 µL, 2 eq., 20 µmol) and DIC (3.1 µL, 2 eq., 20 µmol) in NMP (final concentration 0.1 M). After 6 h of agitation at room temperature, the resin was washed with DMF (5 x 3 mL), CH 2 Cl 2 (5 x 3mL) and DMF (5 x 3 mL). The fully extended PNA-peptide was cleaved from the solid support by treatment with an acidic cocktail of TFA/iPr 3 SiH/H 2 O (95:2.5:2.5, v/v/v, 3 mL) for 1 h and then washed with TFA (2 x 2 mL).
Crude 2 was precipitated from cold Et 2 O and purified by reverse-phase semi-preparative HPLC (10-50% B over 12 min, 0.1 % TFA) to yield 2 exclusively as the diselenide dimer following 
PNA-Peptide Selenoester (8) (H 2 N-[GCCG]-Gln-SePh)
NovaPEG Rink amide resin (30 mg, 0.5 mmol/g, 15 µmol) was loaded with Fmoc-Glu-OAll (6.1 mg, 1 eq., 15 µmol) as outlined in the general coupling procedure, and extended at the N-terminus with PNA monomers via automated Fmoc-SPPS to the desired sequence length. The resin was then solvated in anhydrous CH 2 Cl 2 for 5 minutes before PhSiH 3 (44 µL, 24 eq., 360 µmol) and Pd(PPh 3 ) 4 (4.3 mg, 0.25 eq., 3.75 µmol) were added in CH 2 Cl 2 , maintaining an inert atmosphere. The vessel was gently agitated at room temperature before washing with CH 2 Cl 2 (5 × 3 mL) and DMF (5 × 3 mL).
The resulting deprotected C-terminus was then selenoesterified on-resin as outlined in the general 
PNA-Peptide Thioester (9) (H 2 N-[GCCG]-Gln-SPh)
NovaPEG Rink amide resin (10 mg, 0.5 mmol/g, 5 µmol) was loaded with Fmoc-Glu-OAll (3.0 mg, 1 eq., 5 µmol) as outlined in the general coupling procedure, and extended at the N-terminus with PNA monomers via automated Fmoc-SPPS to the desired sequence length. The resin was then solvated in anhydrous CH 2 Cl 2 for 5 minutes before PhSiH 3 (15 µL, 24 eq., 120 µmol) and Pd(PPh 3 ) 4 (1.4 mg, 0.25 eq., 1.25 µmol) were added in CH 2 Cl 2 , maintaining an inert atmosphere. The vessel was gently agitated at room temperature before washing with CH 2 Cl 2 (5 × 3 mL) and DMF (5 × 3 mL). The resulting deprotected C-terminus was then thioesterified on-resin as outlined in the general procedures using diphenyl disulfide in place of diphenyl diselenide. Cleavage from the solid support was effected by treatment with an acidic cocktail (TFA/TIS/H 2 O 95:2.5:2.5) for 1 h and then concentrated under a stream of N 2 . Following precipitation from Et 2 O and purification by preparative HPLC (10 to 50% B over 15 min, 0.1% TFA), the desired thioester 9 was obtained as a white solid after lyophilisation. 
PNA-Peptide (10) (H 2 N-CysAlaSerAla-[CGGC]-CONH 2 )
NovaPEG Rink amide resin (30 mg, 0.5 mmol/g, 15 µmol) was swollen in CH 2 Cl 2 for 30 minutes.
The desired PNA-peptide sequence was then elongated via automated Fmoc-SPPS as outlined in the general procedures. The fully extended PNA-peptide was cleaved from the solid support by treatment with an acidic cocktail of TFA/iPr 3 SiH/H 2 O (95:2.5:2.5, v/v/v, 3 mL) for 1 h and then washed with TFA (2 x 2 mL). Crude 10 was precipitated from cold Et 2 O and purified by reverse-phase semipreparative HPLC (10-50% B over 12 min, 0.1 % TFA) to yield 10 as a white solid following The ligation of selenoester 1 (0.30 µmol) and diselenide dimer 2 (0.14 µmol) was performed as outlined in the general methods section at a concentration of 100 μM with respect to the diselenide dimer fragment (calculated based on the monomeric mass). After 1 minute, a 20 μL aliquot was removed for LCMS analysis, which confirmed conversion to the symmetrical diselenide ligation product. 
Ligation of PNA-peptide Diselenide Dimer 2 and Peptide Selenoester 6
The ligation of peptide selenoester 6 (0.18 µmol) and diselenide dimer 2 (0.092 µmol) was performed as outlined in the general methods section at a concentration of 100 μM with respect to the diselenide dimer fragment (calculated based on the monomeric mass). After 1 h, a 20 μL aliquot was removed for LCMS analysis, which showed only starting materials remaining, together with some hydrolysis of selenoester 6 (after 24 h). 
Ligation of PNA-peptide Diselenide Dimer 2 and PNA-peptide Selenoesters 1 and 7
The competitive ligation between dimer 2 (0.65 µmol) and selenoesters 1 and 7 (130 µmol, 10 eq.) was performed as outlined in the general methods section at a concentration of 100 μM with respect to the diselenide dimer fragment (calculated based on the monomeric mass). After 5 mins, a 20 μL aliquot was removed for LCMS analysis, which confirmed complete reaction of diselenide 2 with complimentary selenoester 1 to produce ligation product and unreacted non-complementary selenoester 7. The ligation of PNA selenoester 7 and diselenide dimer 2 was performed as outlined in the general methods section at a concentration of 100 μM with respect to the diselenide dimer fragment (calculated based on the monomeric mass). After 30 mins, a 20 μL aliquot was removed for LCMS analysis, which showed only starting materials remaining, together with some hydrolysis of selenoester 7. group from the N-terminus of the PNA sequence. Coupling of (Boc-Sec-OH) 2 was then effected by treatment of the resin with a pre-activated solution of (Boc-Sec-OH) 2 (6.7 mg, 1.0 eq., 12.5 µmol), HOAt (42 µL, 2 eq., 25 µmol) and DIC (3.9 µL, 2 eq., 25 µmol) in NMP (final concentration 0.1 M).
After 6 h of agitation at room temperature, the resin was washed with DMF (5 x 3 mL), CH 2 Cl 2 (5 x S24 3mL) and DMF (5 x 3 mL). 
FITC-labelled selenoester miR-31 PNA probe (12)
NovaPEG Rink amide resin (25 mg, 0.5 mmol/g, 12.5 µmol) was loaded with Fmoc-Glu-OAll (5.1 mg, 1.0 eq., 12.5 µmol) as outlined in the general coupling procedure, and elongated with the PNA sequence via automated Mtt-SPPS (NB: bold residues indicate serine-modified PNA monomers).
With the N-terminal PNA residue Mtt protected, the resin was then solvated in anhydrous CH 2 Cl 2 for 5 minutes before PhSiH 3 (37 µL, 24 eq., 300 µmol) and Pd(PPh 3 ) 4 (3.6 mg, 0.25 eq., 3.13 µmol) were added in CH 2 Cl 2 , maintaining an inert atmosphere. The vessel was gently agitated at room temperature before washing with CH 2 Cl 2 (5 × 3 mL) and DMF (5 × 3 mL). The resulting deprotected C-terminus was then selenoesterified on-resin as outlined in the general procedures. The N-terminal 
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Ligation of Diselenide Dimer Probe 11 and Selenoester Probe 12
The ligation of diselenide dimer probe 11 and selenoester probe 12 was performed as outlined in the general methods section at a concentration of 100 μM with respect to the diselenide dimer fragment (calculated based on monomeric mass), in the presence of 10 μM purified miR-31 DNA template. A 20 μL aliquot was taken for LCMS analysis, which confirmed conversion to the ligation product as well as both starting materials remaining (due to excess of both probes present). 886.33; Excess diselenide 11 R t 1.18 min (5-95% B over 4 min, λ = 280 nm); Excess selenoester 12 R t 1.78 min (5-95% B over 4 min, λ = 280 nm).
Synthesis of miR21 Detection Probes
Biotin-labelled diselenide dimer miR-21 PNA probe (S1)
To NovaPEG Rink amide resin (50 mg, 0.5 mmol/g, 12.5 μmol), Fmoc-Arg(Pbf)-OH (24.4 mg, 37.5 μmol, 3 eq.) was loaded as outlined in the general coupling procedure, followed by Fmoc-Lys(Mtt)-OH (23.5 mg, 37.5 μmol, 3 eq.). The Mtt side-chain protecting group of Lysine was then removed by treatment of the resin with 1:1 HFIP/DCE containing 0.1 M HOBt. The resin was then elongated from the side-chain via automated Mtt-SPPS with PNA monomers (NB: each second PNA monomer was Serine-modified as shown by emboldened residues in synthetic scheme). With the N-terminal Mtt protecting group of the final PNA monomer intact, the Fmoc group of Lysine was deprotected and biotin N-hydroxysuccinimide ester (6.4 mg, 18.75 μmol, 1.5 eq.) was coupled as a solution in DMF with DIPEA (4.35 μL, 25.0 μmol, 2.0 eq.). The resin was then treated with 1:1 v/v HFIP/DCE containing 0.1 M HOBt to remove the Mtt group from the N-terminus of the PNA sequence. Coupling of (Boc-Sec-OH) 2 was then effected by treatment of the resin with a pre-activated solution of (BocSec-OH) 2 (6.7 mg, 1.0 eq., 12.5 µmol), HOAt (42 µL, 2 eq., 25 µmol) and DIC (3.9 µL, 2 eq., 25 µmol) in NMP (final concentration 0.1 M). After 6 h of agitation at room temperature, the resin was washed with DMF (5 x 3 mL), CH 2 Cl 2 (5 x 3mL) and DMF (5 x 3 mL). The fully extended PNApeptide was cleaved from the solid support by treatment with an acidic cocktail of TFA/iPr 3 SiH/H 2 O (95:2.5:2.5, v/v/v, 3 mL) for 1 h and then washed with TFA (2 x 2 mL). Crude S1 was precipitated S29 from cold Et 2 O and purified by reverse-phase semi-preparative HPLC (5-30% B over 12 min, 0.1 % TFA) to yield diselenide dimer S1 following lyophilisation. Calculated M W 3537.37; Yield: 0.9 mg, 0.3 µmol, 2%. Figure S26 . Analytical UPLC trace of HPLC purified S1; R t 1.21 min (5-95% B over 4 min, λ = 280 
FITC-labelled selenoester miR-21 PNA probe (S2)
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Lateral Flow microRNA Detection Assay
DNA templates were purchased from Eurogentec as desalted 100 µM solutions in deionised water.
Stock DNA solutions at 1 µM and 100 nM were prepared in PBS buffer pH 7.4 and stored at -20 °C.
Stock solutions of PNA probes at 10 µM and 1 µM were prepared in anhydrous DMF and stored at -80 °C. 
Assay Procedure
A stock solution of PBS buffer containing 5µM TCEP was prepared at pH 7.0. Stock solutions of PNA probes 11 and 12 (10 µM or 1 µM) were removed from storage at -80 °C and thawed immediately prior to use. Aqueous buffer was aliquoted into an eppendorf tube and heated to the desired temperature for 5 minutes. The DNA analyte/template was added from a stock aqueous solution (1 µM and 100 nM) to the desired final concentration, followed by the diselenide probe then the selenoester probe in a 1:1 stoichiometric ratio. After brief agitation, the assay was allowed to proceed for precisely 2 minutes at the desired temperature. A Milenia® HybriDetect 2T test strip was inserted. The solution was allowed to migrate beyond the control zone and the strip was then removed and allowed to dry at room temperature. The results were evaluated visually and imaged for processing and quantification using ImageJ -an open source Java image processing program.
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Negative Control Assays Figure S30 . Test strip results of negative control assays. Assay buffer is 10 mM PBS containing 5 µM TCEP. Probes 11 and 12 were added as stock solutions in DMF to a final concentration of 10 nM.
Template A was added to a final concentration of 1 nM.
Negative Controls
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Detection of miR-31 in the absence of Ligation
To confirm that the templated selenocystine-selenoester ligation is necessary for miRNA detection, we carried out the assay using diselenide dimer probe 11 and a variant of selenoester probe 12 hydrolysed to a carboxylic acid and therefore unable to participate in the ligation reaction. First, selenoester 12 was allowed to hydrolyse for 2 h as a 50 μM aqueous solution. Digital photograph taken of test strip and image processed using ImageJ, resulting peak areas of test zone band represented graphically.
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Temperature Dependance and Sequence Specificity Table S1 . Assay carried out with 10 nM 11 and 12 probes at varied temperature and concentration of miR- PenStrep at 37 °C in humidified atmosphere containing 5% CO 2 . Cells were lysed by shearing through a 25 G needle in PBS buffer followed by centrifugation at 15,000 rpm for 12 minutes at 5 °C.
Aliquots of 100 µL lysate were stored at -20 °C in 1.5 mL eppendorf tubes.
To perform the miRNA detection assay, a 100 µL aliquot of the desired cell lysate was thawed to room temperature. A solution of TCEP in PBS buffer (100 µM, pH 7.0), was added to the eppendorf containing the lysate to give a final TCEP concentration of 5 µM. The eppendorf was then warmed to 40 °C for 5 minutes. The diselenide probe (miR-31: 11, miR-21: S1) closely followed by the selenoester probe (miR-31: 12, miR-21: S2) were added from 1 µM stock solutions in DMF to a final concentration of 10 nM. A stopwatch was started immediately upon addition of the selenoester probe and the reaction was allowed to proceed for 5 minutes at 40 °C before the insertion of a Milenia® HybriDetect 2T test strip. The solution was allowed to migrate by capillary flow through the test strip which was then removed and left to dry at room temperature. The results were evaluated visually. and B. miR-21 detection by probes S1 and S2 in HeLa, MCF-7 and HEK293T cell lysate.
HeLa
HeLa MCF-7 MCF-7 HEK293T HEK293T
